ArticleJCO precision oncology2025

Risks and Implications of Multiple Actionable Pathogenic Germline Variants Discovered by Panel-Based Cancer Predisposition Testing.

Catherine Neumann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.